Solid Biosciences Inc (SLDB)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.38M | -21.13M | -34.57M | -31.66M | -26.84M | -23.11M | -22.64M | -26.86M |
| Pre Tax Income | -25.09M | -20.41M | -15.15M | -30.07M | -24.63M | -20.98M | -20.34M | -24.3M |
| Net Income | -25.09M | -20.41M | -15.15M | -30.07M | -24.63M | -20.98M | -20.34M | -24.3M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -25.09M | -20.41M | -17.77M | -31.37M | -26.58M | -22.84M | -22.37M | -26.86M |
| EBITDA | -24.66M | -20.69M | -34.03M | -30.95M | -26.14M | -22.53M | -22.05M | -26.54M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 13.62M | 8.09M | 0 |
| Operating Income | -25.58M | -54.86M | -75.69M | -119.32M | -88.41M | -72.25M | -106.45M | -104.25M |
| Pre Tax Income | -23.77M | -53.18M | -74.8M | -117.22M | -88.29M | -72.19M | -85.98M | -96.02M |
| Net Income | -17.23M | -39.32M | -74.8M | -117.22M | -88.29M | -72.19M | -85.98M | -96.02M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -3.363 | -1.011 | -1.007 | -1.381 | -0.713 | -0.484 | -1.471 | -1.626 |
| EBIT | -24.14M | -53.4M | -75.42M | -118.8M | -88.41M | -72.25M | -88.6M | -103.16M |
| EBITDA | -25.52M | -54.41M | -74.12M | -116.49M | -84.48M | -69.29M | -104.04M | -101.67M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
